• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高脂血症患者中活性 GLP-1 分泌受损:一种新的脂毒性模式?

Impaired secretion of active GLP-1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm?

机构信息

Department of Endocrinology and Metabolism, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, China.

Institute of Endocrinology and Metabolism, Shandong Academy of Clinical Medicine, Jinan, China.

出版信息

Diabetes Metab Res Rev. 2018 Feb;34(2). doi: 10.1002/dmrr.2964. Epub 2017 Dec 14.

DOI:10.1002/dmrr.2964
PMID:29135069
Abstract

BACKGROUND

Lipotoxicity plays an important role in the pathogenesis of β-cell dysfunction. Glucagon-like peptide-1 (GLP-1) is an incretin hormone that exerts beneficial effects on the number and function of islet β cells. However, the effect of lipotoxicity on GLP-1 secretion is still unknown.

METHODS

Twenty-five patients who were newly diagnosed with diabetes were recruited from 400 subjects based on 75-g Oral Glucose Tolerance Test. Patients were divided into diabetes (DM) and DM combined with hypertriglyceridaemia (DM + HTG) groups according to their serum triglyceride (TG) levels. Seventy-one normal controls and 17 patients with isolated hypertriglyceridaemia were matched by age and gender.

RESULTS

Total and active fasting GLP-1 and 2-hour GLP-1 levels were not significantly altered among the 4 groups. However, total and active ΔGLP-1 levels (the difference between 2-hour GLP-1 and fasting GLP-1 levels) were significantly reduced in the isolated HTG, DM, and DM + HTG groups, particularly the DM + HTG group. The ratio of serum active GLP-1 (AGLP-1) to total GLP-1 (TGLP-1) levels was also decreased in patients with isolated HTG, suggesting that active GLP-1 secretion may be more seriously impaired. Both ΔTGLP-1 and ΔAGLP-1 levels were negatively correlated with serum TG levels, body mass index and fasting plasma glucose (FPG) levels and positively correlated with HDL-C levels. According to the multivariate linear regression analysis, only TG and FPG levels were independently associated with ΔTGLP-1 and ΔAGLP-1 levels.

CONCLUSION

Impaired GLP-1 secretion was associated with hypertriglyceridaemia and diabetes, and a more obvious association was noted in hypertriglyceridaemic patients with diabetes.

摘要

背景

脂毒性在β细胞功能障碍的发病机制中起重要作用。胰高血糖素样肽-1(GLP-1)是一种肠促胰岛素激素,对胰岛β细胞的数量和功能有有益的影响。然而,脂毒性对 GLP-1 分泌的影响尚不清楚。

方法

根据 75g 口服葡萄糖耐量试验,从 400 名受试者中招募了 25 名新诊断为糖尿病的患者。根据血清甘油三酯(TG)水平,患者被分为糖尿病(DM)和糖尿病合并高甘油三酯血症(DM+HTG)组。匹配了 71 名正常对照者和 17 名单纯高甘油三酯血症患者的年龄和性别。

结果

4 组间空腹和 2 小时 GLP-1 水平以及总 GLP-1 和活性 GLP-1 差值(2 小时 GLP-1 与空腹 GLP-1 水平之差)均无明显差异。然而,单纯 HTG、DM 和 DM+HTG 组的总 GLP-1 和活性 GLP-1 差值明显降低,DM+HTG 组尤为明显。血清活性 GLP-1(AGLP-1)与总 GLP-1(TGLP-1)的比值在单纯 HTG 患者中也降低,提示活性 GLP-1 分泌可能受到更严重的损害。ΔTGLP-1 和 ΔAGLP-1 水平与血清 TG 水平、体重指数和空腹血糖(FPG)水平呈负相关,与高密度脂蛋白胆固醇(HDL-C)水平呈正相关。根据多元线性回归分析,只有 TG 和 FPG 水平与 ΔTGLP-1 和 ΔAGLP-1 水平独立相关。

结论

GLP-1 分泌受损与高甘油三酯血症和糖尿病有关,在合并糖尿病的高甘油三酯血症患者中更为明显。

相似文献

1
Impaired secretion of active GLP-1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm?高脂血症患者中活性 GLP-1 分泌受损:一种新的脂毒性模式?
Diabetes Metab Res Rev. 2018 Feb;34(2). doi: 10.1002/dmrr.2964. Epub 2017 Dec 14.
2
Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.新诊断2型糖尿病患者口服葡萄糖耐量试验期间胰高血糖素样肽1分泌受损。
Saudi Med J. 2016 Jan;37(1):48-54. doi: 10.15537/smj.2016.1.12035.
3
[The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].新诊断2型糖尿病患者胃肠道激素胰高血糖素样肽-1、肽YY及胃饥饿素的变化
Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 Sep;44(5):774-8.
4
Reduced plasma levels of glucagon-like peptide-1 in elderly men are associated with impaired glucose tolerance but not with coronary heart disease.老年男性胰高血糖素样肽-1 水平降低与葡萄糖耐量受损有关,但与冠心病无关。
Diabetologia. 2010 Feb;53(2):277-80. doi: 10.1007/s00125-009-1596-0. Epub 2009 Nov 21.
5
Preserved GLP-1 and exaggerated GIP secretion in type 2 diabetes and relationships with triglycerides and ALT.2 型糖尿病患者 GLP-1 水平升高和 GIP 分泌增加,以及与甘油三酯和 ALT 的关系。
Eur J Endocrinol. 2013 Sep 12;169(4):421-30. doi: 10.1530/EJE-13-0487. Print 2013 Oct.
6
Patients With Long-QT Syndrome Caused by Impaired -Encoded K11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated With Reactive Hypoglycemia.由KCNE1编码的K11.1钾通道功能受损引起的长QT综合征患者,其内分泌胰腺和肠促胰岛素功能亢进,并伴有反应性低血糖。
Circulation. 2017 May 2;135(18):1705-1719. doi: 10.1161/CIRCULATIONAHA.116.024279. Epub 2017 Feb 24.
7
The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes.新诊断 2 型糖尿病患者短期持续皮下胰岛素输注治疗对空腹胰高血糖素样肽-1 浓度的影响。
Diabetes Res Clin Pract. 2018 Apr;138:246-252. doi: 10.1016/j.diabres.2018.01.033. Epub 2018 Feb 3.
8
Altered Plasma Levels of Glucagon, GLP-1 and Glicentin During OGTT in Adolescents With Obesity and Type 2 Diabetes.肥胖和2型糖尿病青少年口服葡萄糖耐量试验期间胰高血糖素、胰高血糖素样肽-1和胃泌酸调节素的血浆水平变化
J Clin Endocrinol Metab. 2016 Mar;101(3):1181-9. doi: 10.1210/jc.2015-3885. Epub 2016 Jan 8.
9
Impaired Secretion of Glucagon-Like Peptide 1 in Patients with Colorectal Adenoma after an Oral Glucose Load.口服葡萄糖负荷后,结直肠腺瘤患者胰高血糖素样肽 1 分泌受损。
Digestion. 2018;97(4):324-332. doi: 10.1159/000486129. Epub 2018 Mar 14.
10
The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus.胰高血糖素样肽-1(GLP-1)水平较低是2型糖尿病的一个风险因素。
BMC Res Notes. 2014 Nov 26;7:849. doi: 10.1186/1756-0500-7-849.

引用本文的文献

1
Association Between the Trajectories of the Atherogenic Index of Plasma and Prediabetes Progression to Diabetes: A Retrospective Cohort Study.血浆致动脉粥样硬化指数轨迹与糖尿病前期进展为糖尿病之间的关联:一项回顾性队列研究
Diabetes Metab Syndr Obes. 2024 Dec 6;17:4689-4699. doi: 10.2147/DMSO.S481578. eCollection 2024.
2
The Impact of Incretin-Based Medications on Lipid Metabolism.基于肠促胰岛素的药物对脂代谢的影响。
J Diabetes Res. 2021 Dec 29;2021:1815178. doi: 10.1155/2021/1815178. eCollection 2021.